Study Notes for BS2013: Physiology and Pharmacology
BS2013: Physiology and Pharmacology
Topic Overview
- Topic 3: Applied Pharmacology
- Part 1: General Principles
- Part 2: Kinetic Models
Recommended Resources
- TEXTBOOK:
- Chapters: 9-11 of Rang and Dale’s Pharmacology (9th Edition)
- Access: Available on the University Catalogue through the Blackboard site: Readings & Sources > Module Reading List > Reading for Pharmacokinetics Lectures
Introduction to Pharmacokinetics
- Effectiveness of Drugs:
- Pharmacokinetics refers to how drugs are processed in the body, covering the following key stages:
- Absorption
- Distribution
- Metabolism
- Excretion
- These factors determine the concentration and time-course of drug distribution in the body, influencing optimal dosage and dosing regimens.
- Drug-Receptor Interactions:
- At the molecular level, these interactions relate to concepts such as potency and efficacy.
Drug Absorption
General Mechanism:
- Drugs, in most cases, travel to tissues via the plasma.Routes of Administration:
1. Oral & Swallowed:
- Common for small molecule drugs; may be subject to degradation in the GI tract.
2. Sublingual:
- Rapid absorption from the oral cavity (e.g., Glyceryl Trinitrate for vasodilation).
3. Rectal:
- Provides local or systemic effects when oral intake is not possible (e.g., nausea/vomiting).
4. Epithelial Surfaces:
- Includes skin, cornea, and nasal mucosa.
5. Inhalation:
- Utilized for gaseous anaesthetics and bronchodilators.
6. Injection:
- Most direct route, with forms including intravenous (fastest), subcutaneous, intramuscular, and intrathecal (lumbar puncture).Factors Affecting Absorption:
1. Site/Method of Administration
2. Molecular Weight:
- Major determinant of the rate of diffusion.
3. Lipid Solubility:
- Critical for crossing lipid membranes by diffusion.
4. pH and Ionization:
- Many drugs are weak acids or bases.
- Example: Weak acid HA ⇌ H⁺ + A⁻ with the equation
- Note that at low pH, weak acids remain mostly un-ionized, allowing diffusion across lipid bilayers (e.g., stomach pH 1.5-2).
5. Carrier Mediated Transport:
- Active or facilitated transport for polar molecules such as amino acids and metal ions.
- Example: Gases, with diffusivity (D \propto \frac{1}{\sqrt{\text{MWt}}}).
Drug Distribution
Major Body Compartments:
1. Extracellular Fluids:
- Plasma: 4.5% body weight
- Interstitial Fluid: 16%
- Lymph: 1-2%
2. Intracellular Fluids:
- 30-40%
3. Transcellular Fluids:
- Examples include cerebrospinal fluid (CSF) and intraocular fluid, constituting 2.5%.
4. Fat:
- Accounts for 20%, influencing drug distribution based on lipid solubility and permeability.Blood-Brain Barrier:
- Comprised of endothelial cells forming tight junctions, which create a barrier to systemically acting drugs (typically those >400-500 daltons).
- Drugs must cross cell membranes and tight junctions may become leaky during inflammation.
- Example Experiment: Paul Ehrlich's Injection of water-soluble dye (trypan blue), which stained all organs except the brain; conversely, injecting it into the brain stained it but not the rest of the body.
Drug Metabolism
Definition:
- Refers to the enzymatic modification of drugs prior to excretion, usually rendering the drugs pharmacologically inactive, though exceptions exist (e.g., thienopyridines serve as prodrugs for P2Y12 inhibition).Phases of Metabolism:
1. Phase 1
- Involves oxidation, reduction, or hydrolysis via the Cytochrome P450 (CYP) monooxygenase system, primarily located in the smooth endoplasmic reticulum of the liver.
- Notable CYP enzymes (e.g., CYP1A2 metabolizes caffeine and paracetamol).
- Other systems include alcohol dehydrogenase (cytoplasmic).
2. Phase 2
- Involves conjugation, the addition of substituent groups (e.g., methyl, sulfate, acetyl) that generally inactivate substances.
- Both phases decrease lipid solubility, therefore enhancing kidney clearance.
Drug Excretion
General Mechanism:
- Drugs are eliminated from the body primarily through renal mechanisms but also via gastrointestinal and pulmonary pathways.Renal Excretion:
- Four basic processes:
1. Glomerular Filtration (GF):
- Non-discriminant filtration of protein-free plasma into Bowman’s capsule, approximately 20% of glomerular blood flow with a cut-off near 20 kDa, with 99% of water reabsorbed.
2. Tubular Reabsorption (TR):
- Selective movement from the tubular lumen into peritubular capillaries.
3. Tubular Secretion (TS):
- Selective movement of non-filtered substances from peritubular capillaries into tubular lumen.
4. Urine Excretion (UE):
- Creation of the medullary vertical osmotic gradient.
- Characteristics of Renal Excretion:
- Active tubular secretion is crucial for weak acids and plasma protein-bound drugs, with poor reabsorption for poorly lipid-soluble compounds.
- Renal disease may impair drug clearance and result in toxicity.Gastrointestinal (GI) Excretion:
- Biliary excretion from the liver; relevant for certain drugs.Lung Excretion:
- Expulsion of volatile or gaseous agents; example includes rapid clearance of penicillin versus the slower clearance of diazepam, which is contingent on urine pH affecting weak acid/base excretion.
Kinetic Models in Pharmacokinetics
- Purpose of Kinetic Models:
- To predict the time-course of drug action, integrating absorption, distribution, metabolism, and elimination.
One-Compartment Model
- Concept:
- Represents the body as a single well-stirred compartment where drug elimination is proportional to plasma drug concentration. - Key Variables:
- (K_A): Rate of drug absorption
- (V_d): Volume of drug distribution
- (C_P): Concentration of drug in the compartment
- (K_{El}): Rate of elimination (excretion + metabolism), also referred to as clearance. - Single Drug Infusion:
- The decay of the drug concentration follows an exponential time-course characterized by the half-life (T½), which indicates the time taken for the concentration to reduce by 50%.
- For an intravenous bolus, drug concentration spiking occurs instantly, later declining exponentially.
Two-Compartment Model
- Concept:
- More complex, applicable to many drugs where drug disappearance does not follow a single exponential decay.
- Characterized by a central compartment (plasma) and a peripheral compartment (tissues). - Key Rate Constants in Two-Compartment Model:
- (K_{Pl:Tiss}): Rate of transfer from plasma to tissues, typically greater than (K_{El}). - Decay Phases:
- Slow decay estimates the elimination rate constant.
Summary Points on Pharmacokinetics
- Drug Administration Routes:
- Approximately six routes exist, including inhalation and injection. - Chemical Properties:
- Properties such as lipid solubility govern drug distribution across body compartments due to their effects on absorption, distribution, metabolism, and excretion. - Blood-Brain Barrier:
- Access to the brain compartment is tightly regulated due to the properties of the blood-brain barrier. - One-Compartment Model:
- Models the kinetics of drug concentration with single exponential decay, while more complex models are often required to accurately depict multi-compartmental behavior.
Sample Single Best Answer Questions (SBAQ)
SBAQ 1:
- Question: A patient is taking drug K once a day to achieve the optimal average plasma concentration required to treat their medical condition. After starting an additional drug F that promotes kidney excretion of drug K, what could result from taking both drugs compared to just drug K?
- Options:
- A. No change in the average concentration of drug K in the plasma
- B. Need to increase frequency of administration of drug K to achieve same average effective concentration in plasma
- C. Increase in average concentration of drug K in the plasma
- D. Increase in the half-life of drug K in the plasmaSBAQ 2:
- Question: If the half-life of a drug in the body is 2 hours, how long would it take for the concentration of the drug to drop from 4 µg/ml to 125 ng/ml?
- Options:
- A. 5 hours
- B. 8 hours
- C. 10 hours
- D. 16 hours
- Calculation Path:
- Initial concentration: 4 µg/ml = 4000 ng/ml.
- Steps: 4000 → 2000 → 1000 → 500 → 250 → 125 = 5 half-lives = 10 hours.